Investigation of the prevalence and clinical implications of erbb2 exon 16 skipping mutations in chinese pan-cancer patients

HIGHLIGHTS

• who: Yanhong Shang and collaborators from the Medical University of Vienna, Austria have published the Article: Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients, in the Journal: (JOURNAL)
• what: The study investigated the prevalence and clinical significance of ERBB2DEx16 in Chinese pan-cancer patients (n=40996).
• how: Sequence data_analysis Sequence data were analyzed using the Burning Rock analysis system as previously described .

SUMMARY

Prevalence of 0.01-0.19% in various solid tumor types. A deeper molecular understanding of . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.